Clinical Trial: Maintaining Abstinence in Chronic Cigarette Smokers


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Maintaining Abstinence in Chronic Cigarette Smokers - 1

This study is currently recruiting patients.

Sponsored by:	National Institute on Drug Abuse (NIDA)
Information provided by:	National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this study is to evaluate the extended pharmacological and psychological treatment for chronic cigarette smokers.

Condition	Treatment or Intervention	Phase
Tobacco Use Disorder	Drug: Bupropion	Phase II

MedlinePlus related topics: Smoking

Study Type: Interventional
Study Design: Treatment, Uncontrolled, Efficacy Study

Official Title: Maintaining Abstinence in Chronic Cigarette Smokers

Further Study Details:

Expected Total Enrollment: 400

Study start: December 2002

Eligibility

Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both

Criteria

chronic cigarette smokers of at least 10 cigarettes per day

Inclusion Criteria:

multiple

Exclusion Criteria:

multiple

Location and Contact Information

Sharon M Hall, Ph.D. (415)476-7574 smh@itsa.ucsf.edu

California
San Francisco, San Francisco, California, United States; Recruiting

Gary Humfleet, Ph.D. 415-476-7674 hac@itsa.ucsf.edu

Study chairs or principal investigators

Sharon M Hall, Ph.D., Principal Investigator, University of California, San Francisco

More Information

http://www.ucsf.edu/nosmoke

Study ID Numbers: NIDA-15732-1; R01-15732-1
Record last reviewed: June 2004
Record first received: July 15, 2004
ClinicalTrials.gov Identifier: NCT00087880
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services